Table 1.
Summary of the pathological nsSNPs and their effects.
Purpose | Tool Used | ANGPTL3 | ANGPTL8 | ||
---|---|---|---|---|---|
Effect of SNP on protein | nsSNP analyzer | Pathological | Neutral | Pathological | Neutral |
83 | 135 | 12 | 71 | ||
SNP&GO | 115 | 103 | 38 | 45 | |
PROVEAN | 67 | 151 | 30 | 53 | |
PMUT | 78 | 140 | 4 | 79 | |
Total high-risk SNPs | Predicted by 3 or >3 | 67 | 12 | ||
Protein stability upon SNP | I-Mutant | Decrease | Increase | Decrease | Increase |
60 | 7 | 6 | 1 | ||
No. of conserved residues | ClustalO | 50 | All | ||
Ligand binding | FTsite and COACH | 8 | 0 | ||
Phosphorylation sites | Netphos 2.0 | 49 | 8 | ||
Glycosylation sites | YinOYang | 8 | 5 | ||
Ubiquitination sites (≥2) | iUbiq-lys, CKSAAP UbSite, BDM-PUB | 0 | 1 | ||
Palmitoylation sites | CSS-PALM 3.0 | 0 | 1 | ||
Methylation sites | PMes | 7 | 0 | ||
Acetylation sites | PAIL and ASEB | 15 | 3 | ||
Sumoylation sites | SUMOplotTM SUMOhydro and SUMOsp | 3 | 0 | ||
Total PTM sites | - | 82 | 18 |